Late recurrence after radical cystectomy: patterns, risk factors and outcomes

The Journal of Urology
Brian J LinderIgor Frank

Abstract

We evaluated the outcome in patients with late recurrence of urothelial carcinoma after radical cystectomy. We identified 2,091 patients who underwent radical cystectomy at our institution between 1980 and 2006. Survival was estimated using the Kaplan-Meier method and compared based on recurrence timing (less than 5 years vs 5 or greater) and location (urothelial vs nonurothelial) using the log rank test. Cox proportional hazard regression models were used to evaluate variables associated with late recurrence and death from bladder cancer. Median postoperative followup was 16.6 years. Late recurrence was identified in 82 patients (3.9%). On multivariate analysis younger age (p = 0.0008), nonmuscle invasive disease (p = 0.01) and prostatic urethral involvement (p <0.0001) were significantly associated with an increased risk of late recurrence. Five-year post-recurrence cancer specific survival was significantly worse after recurrence within 5 years from radical cystectomy vs after late recurrence (17% vs 37%, p = 0.001). Patients with nonurothelial late recurrence had adverse 5-year cancer specific survival compared to those with urothelial late recurrence (19% vs 67%, p <0.0001). On multivariate analysis younger patient age (HR...Continue Reading

References

Sep 1, 1990·The Journal of Urology·S W Hardeman, M S Soloway
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H W Herr
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SteinD G Skinner
Dec 19, 2003·The Urologic Clinics of North America·Bernard H BochnerCheryl T Lee
Feb 7, 2007·Urology·UNKNOWN World Health Organization (WHO) Consensus Conference on Bladder CancerBjoern G Volkmer
Feb 24, 2009·The Journal of Urology·Bjoern G VolkmerRichard E Hautmann
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Dec 21, 2010·The Journal of Urology·Mark S ShimkoIgor Frank
Apr 2, 2011·European Urology·Arnulf StenzlUNKNOWN European Association of Urology (EAU)
Jul 9, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Deepa NaishadhamAhmedin Jemal
Aug 5, 2011·BJU International·Anirban P MitraSiamak Daneshmand
Aug 30, 2011·European Urology·Stephen A BoorjianIgor Frank
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Mar 2, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M MoschiniR Colombo
Jul 16, 2016·International Journal of Urology : Official Journal of the Japanese Urological Association·Quentin AlimiBenoit Peyronnet
Oct 11, 2016·European Urology·Georgios GakisWassim Kassouf
Nov 8, 2016·Journal of Clinical Urology·Friedrich-Carl von RundstedtSeth P Lerner
Jun 27, 2017·Urology·Guru Sonpavde, Mark A Preston
Apr 29, 2016·Molecular and Clinical Oncology·Taito NakanoMikio Namiki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.